General Information of the Cell Line
Cell Line ID
CL000812
Cell Line Name
CHRF
Synonyms
CHRF288-11
CHRF-288
Category
Cancer cell line
Organism
Homo sapiens (Human)
Tissue Information
Eye
Disease
Childhood acute megakaryoblastic leukemia (NCIt: C7972)
Acute megakaryoblastic leukemia (ORDO: Orphanet_518)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01871, Proteinase-activated receptor 1
Compound ID Compound Name Compound Formula
CP0466885
CAS_141923-40-2
   Show/Hide
C34H57N11O8
 1
1
IC50 = 550 nM
   TI
   LI
   LO
   TS
CP0897075
5-[(E)-3-(4-Fluoro-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C36H46FN11O5
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0422275
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]pyridine-3-carboxamide
   Show/Hide
C30H42N8O4
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0890536
5-[(E)-3-(2-Chloro-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C36H46ClN11O5
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0942278
5-[(E)-3-(4-Chloro-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C36H46ClN11O5
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0565780
4-Oxo-4H-chromene-2-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C34H43N7O6
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0862614
5-[(E)-3-(2-Nitro-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C36H46N12O7
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0447402
5-Bromo-N-{(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-nicotinamide
   Show/Hide
C30H41BrN8O4
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0476582
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C27H41N11O4
 1
1
IC50 = 1900 nM
   TI
   LI
   LO
   TS
CP0391983
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-cyclohexyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C27H47N11O4
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0463639
3-Amino-N-{(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-benzamide
   Show/Hide
C31H44N8O4
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0470574
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-phenyl-ethyl}-amide
   Show/Hide
C27H35N11O4
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0539516
6-Amino-N-{(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-nicotinamide
   Show/Hide
C30H43N9O4
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0897046
5-((Z)-2-Fluoro-3-phenyl-acryloylamino)-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C36H46FN11O5
 1
1
IC50 = 2200 nM
   TI
   LI
   LO
   TS
CP0466153
Benzo[b]thiophene-2-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C33H43N7O4S
 1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0539029
2-Amino-N-{(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-nicotinamide
   Show/Hide
C30H43N9O4
 1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0448864
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]-6-chloropyridine-3-carboxamide
   Show/Hide
C30H41ClN8O4
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0573402
Biphenylene-2-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C37H45N7O4
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0478257
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]-5,6-dichloropyridine-3-carboxamide
   Show/Hide
C30H40Cl2N8O4
 1
1
IC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0498159
4-Amino-N-{(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-benzamide
   Show/Hide
C31H44N8O4
 1
1
IC50 = 2900 nM
   TI
   LI
   LO
   TS
CP0502677
Benzofuran-2-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C33H43N7O5
 1
1
IC50 = 3000 nM
   TI
   LI
   LO
   TS
CP0538830
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]quinoxaline-2-carboxamide
   Show/Hide
C33H43N9O4
 1
1
IC50 = 3100 nM
   TI
   LI
   LO
   TS
CP0878442
5-((E)-2,3-Diphenyl-acryloylamino)-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C42H51N11O5
 1
1
IC50 = 3100 nM
   TI
   LI
   LO
   TS
CP0469541
1H-Benzoimidazole-5-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-phenyl-ethyl}-amide
   Show/Hide
C32H37N9O4
 1
1
IC50 = 4000 nM
   TI
   LI
   LO
   TS
CP0518474
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-thiophen-2-yl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C25H39N11O4S
 1
1
IC50 = 4000 nM
   TI
   LI
   LO
   TS
CP0900187
5-[(E)-3-(4-Methoxy-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C37H49N11O6
 1
1
IC50 = 4000 nM
   TI
   LI
   LO
   TS
CP0920813
5-((E)-2-Methyl-3-phenyl-acryloylamino)-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C37H49N11O5
 1
1
IC50 = 4200 nM
   TI
   LI
   LO
   TS
CP0454786
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]pyridine-2-carboxamide
   Show/Hide
C30H42N8O4
 1
1
IC50 = 4400 nM
   TI
   LI
   LO
   TS
CP0967372
5-((E)-3-Thiophen-2-yl-acryloylamino)-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C34H45N11O5S
 1
1
IC50 = 4400 nM
   TI
   LI
   LO
   TS
CP0878954
(S)-2-{(S)-3-Cyclohexyl-2-[(E)-(3-phenyl-acryloyl)amino]-propionylamino}-5-guanidino-pentanoic acid ((S)-1-carbamoyl-2-phenyl-ethyl)-amide
   Show/Hide
C33H45N7O4
 1
1
IC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0405107
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-5-amino-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-pentylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C27H41N9O4
 1
1
IC50 = 5400 nM
   TI
   LI
   LO
   TS
CP0916450
(S)-2-[(S)-3-Cyclohexyl-2-((E)-3-pyridin-3-yl-acryloylamino)-propionylamino]-5-guanidino-pentanoic acid ((S)-1-carbamoyl-2-phenyl-ethyl)-amide
   Show/Hide
C32H44N8O4
 1
1
IC50 = 5500 nM
   TI
   LI
   LO
   TS
CP0408377
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid ((S)-1-{(S)-1-[(S)-1-carbamoyl-2-(4-hydroxy-phenyl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-cyclohexyl-ethyl)-amide
   Show/Hide
C27H41N11O5
 1
1
IC50 = 6000 nM
   TI
   LI
   LO
   TS
CP0916777
5-[(E)-(3-Phenyl-acryloyl)amino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C36H47N11O5
 1
1
IC50 = 6400 nM
   TI
   LI
   LO
   TS
CP0460571
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]pyridine-4-carboxamide
   Show/Hide
C30H42N8O4
 1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
CP0468060
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid ((S)-1-{(S)-1-[((S)-carbamoyl-phenyl-methyl)-carbamoyl]-4-guanidino-butylcarbamoyl}-2-cyclohexyl-ethyl)-amide
   Show/Hide
C26H39N11O4
 1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
CP0391523
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]-2-chloropyridine-3-carboxamide
   Show/Hide
C30H41ClN8O4
 1
1
IC50 = 7600 nM
   TI
   LI
   LO
   TS
CP0438178
3-Amino-pyrazine-2-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C29H42N10O4
 1
1
IC50 = 8500 nM
   TI
   LI
   LO
   TS
CP0847147
5-[(E)-3-(3-Nitro-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C36H46N12O7
 1
1
IC50 = 8500 nM
   TI
   LI
   LO
   TS
CP0391520
(S)-2-[(S)-2-(3-Amino-propionylamino)-3-cyclohexyl-propionylamino]-5-guanidino-pentanoic acid ((S)-1-carbamoyl-2-phenyl-ethyl)-amide
   Show/Hide
C27H44N8O4
 1
1
IC50 = 9000 nM
   TI
   LI
   LO
   TS
CP0463456
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]thiadiazole-4-carboxamide
   Show/Hide
C27H39N9O4S
 1
1
IC50 = 9400 nM
   TI
   LI
   LO
   TS
CP0451361
1H-Pyrrole-2-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C29H42N8O4
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0470616
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-3-phenyl-propylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C28H43N11O4
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0538903
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C21H37N11O4
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0528757
Biphenyl-4-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C37H47N7O4
 1
1
IC50 = 13000 nM
   TI
   LI
   LO
   TS
CP0907976
5-[(E)-3-(3-Chloro-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C36H46ClN11O5
 1
1
IC50 = 15000 nM
   TI
   LI
   LO
   TS
CP0463424
Benzo[1,4]dioxine-2-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C33H43N7O6
 1
1
IC50 = 16000 nM
   TI
   LI
   LO
   TS
CP0911952
5-((E)-3-Naphthalen-1-yl-acryloylamino)-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C40H49N11O5
 1
1
IC50 = 16000 nM
   TI
   LI
   LO
   TS
CP0943099
2-Oxo-2,3-dihydro-pyridine-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C30H42N8O5
 1
1
IC50 = 16000 nM
   TI
   LI
   LO
   TS
CP0506360
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-ethylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C24H34N8O4
 1
1
IC50 = 18000 nM
   TI
   LI
   LO
   TS
CP0377727
N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]furan-3-carboxamide
   Show/Hide
C29H41N7O5
 1
1
IC50 = 25000 nM
   TI
   LI
   LO
   TS
CP0455439
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid ((S)-1-{(S)-1-[(S)-1-carbamoyl-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-4-guanidino-butylcarbamoyl}-2-cyclohexyl-ethyl)-amide
   Show/Hide
C24H39N13O4
 1
1
IC50 = 27000 nM
   TI
   LI
   LO
   TS
CP0921616
5-[(E)-3-(4-Trifluoromethyl-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C37H46F3N11O5
 1
1
IC50 = 30000 nM
   TI
   LI
   LO
   TS
CP0935317
5-[(E)-3-(4-Cyano-phenyl)-acryloylamino]-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C37H46N12O5
 1
1
IC50 = 31000 nM
   TI
   LI
   LO
   TS
CP0530538
5-Amino-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-ethyl}-amide
   Show/Hide
C21H31N11O4
 1
1
IC50 = 46000 nM
   TI
   LI
   LO
   TS
CP0521951
1H-Indole-2-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C33H44N8O4
 1
1
IC50 = 56000 nM
   TI
   LI
   LO
   TS
CP0904756
5-((E)-3-1H-Indol-3-yl-acryloylamino)-1H-[1,2,4]triazole-3-carboxylic acid {(S)-1-[(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butylcarbamoyl]-2-cyclohexyl-ethyl}-amide
   Show/Hide
C38H48N12O5
 1
1
IC50 = 100000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Eye)
Cell Line Name Organism Disease
GTM-3 Homo sapiens (Human) Glaucoma
Y-79 Homo sapiens (Human) Retinoblastoma
HCE-T Homo sapiens (Human) -
MIO-M1 Homo sapiens (Human) -
RGC-5 Mus musculus (Mouse) -
661W Mus musculus (Mouse) -
FG-9307 Paralichthys olivaceus (Bastard halibut) -